Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d4acf8e67a810f332df5921d82fc7f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e17596cb58229204e29f19810017a007 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00 |
filingDate |
2006-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c55eff35ba3f8d19cbd37697f5b8285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0fec1751cae56b3030993688d63bcb9 |
publicationDate |
2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8080237-B2 |
titleOfInvention |
Use of tellurium compounds for protection from ultra-violet radiation |
abstract |
Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma an/or actinic keratosis is also provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580770-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9986912-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012302529-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014015951-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8913118-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9173570-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014052313-A1 |
priorityDate |
2005-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |